Open AccessProgressive pulmonary fibrosis during a pandemic: assessment of risk factors and modern approaches to treatment
Author(s) -
Е Н Попова,
AUTHOR_ID,
A. B. Ponomarev,
AUTHOR_ID
Publication year - 2021
Publication title -
kliničeskij razbor v obŝej medicine
Language(s) - English
Resource type - Journals
eISSN - 2782-5671
pISSN - 2713-2552
DOI - 10.47407/kr2021.2.1.00026
Subject(s) - pandemic , medicine , intensive care medicine , incidence (geometry) , covid-19 , pulmonary fibrosis , residual risk , fibrosis , disease , infectious disease (medical specialty) , physics , optics
Complex of medicine that increases the body's resistance to the damaging effects of viruses during a pandemic in the long term will be an important tool not only to reduce the overall incidence of diseases, but also to improve the prognosis of those who have been ill due to the reduction of residual fibrotic changes in the lungs.